ADAPTUS / DELAMAN Tablet Ref.[10476] Active ingredients: Delapril and Manidipine

Source: European Medicines Agency (EU) 

Product name and form

ADAPTUS/DELAMAN 30 mg + 10 mg tablets.

Pharmaceutical Form

Tablet.

Salmon-pink, round, scored tablet.

The tablet can be divided into equal doses.

Qualitative and quantitative composition

Each tablet contains 30 mg of delapril hydrochloride and 10 mg of manidipine hydrochloride.

Excipients with known effect:

67.60 mg lactose monohydrate/tablet
0.08 mg sunset yellow (E110) Aluminum lake/tablet

For the full list of excipients, see section 6.1.

Active Ingredient Description
Delapril and Manidipine

Fixed dose combination of delapril, an inhibitor of the angiotensin conversion enzyme, and manidipine, a dyhydropyridine calcium-antagonist with antihypertensive activity and nephroprotecting properties. The combination of these active ingredients through complementary mechanisms of action produces a synergistic antihypertensive effect, reducing blood pressure in a greater measure than with the single constituents.

List of Excipients

Lactose monohydrate
Low-substituted hydroxypropylcellulose
Hydroxypropylcellulose
Magnesium stearate
Riboflavine
Sunset Yellow (E110) Aluminium lake

Pack sizes and marketing

Primary container: bottle with child resistant closure. A silica gel tablet is included in the screw cap as dehydrating agent.

Final package: printed thin-cardboard box.

Pack sizes of 14, 28, 50 tablets of 30mg delapril and 10mg manidipine.

Pack sizes of 100 tablets (50x2 bottles) of 30mg delapril and 10mg manidipine.

Not all pack sizes may be marketed.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.